EXAS vs GLAD · rev $2.76B vs P/E 10, rev $87.3M
EXACT Sciences Corporation (EXAS) versus Gladstone Capital Corporation (GLAD) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Gladstone Capital Corporation (GLAD) is a asset management company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported GLAD revenue for 2025-09-30 was $87.3M. Net income was $57.2M. Revenue was down 6.4% from 2024-09-30 to 2025-09-30. GLAD currently screens at market cap $427.9M and trailing P/E 10.1.
EXAS currently screens at market cap $20.03B. GLAD currently screens at market cap $427.9M and trailing P/E 10.1.
Not investment advice. Open the EXAS and GLAD stock pages for the full models.
Not investment advice.